NDC 50242-202 – Evrysdi

Risdiplam 5 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC50242-202

Product details

Brand name
Evrysdi
Generic name
Risdiplam
Labeler
Genentech, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA219285
Marketed since
February 11, 2025
Listing expires
December 31, 2027
Pharmacologic class
Survival of Motor Neuron 2 Splicing Modifier

Active ingredients

Uses, dosage, side effects and warnings for Evrysdi →

Package NDC codes (1)

Package NDCDescriptionSince
50242-202-011 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTICFeb 11, 2025

Other Evrysdi products